Sommer, C., Neuhaus, V., Gogesch, P., Flandre, T., Dehmel, S., & Sewald, K. (2024). Type 2 responses determine skin rash during recombinant interleukin-2 therapy. Journal of Immunotoxicology, 21, S48. https://doi.org/10.1080/1547691X.2024.2343359
Chicago Style (17th ed.) CitationSommer, Charline, Vanessa Neuhaus, Patricia Gogesch, Thierry Flandre, Susann Dehmel, and Katherina Sewald. "Type 2 Responses Determine Skin Rash During Recombinant Interleukin-2 Therapy." Journal of Immunotoxicology 21 (2024): S48. https://doi.org/10.1080/1547691X.2024.2343359.
MLA (9th ed.) CitationSommer, Charline, et al. "Type 2 Responses Determine Skin Rash During Recombinant Interleukin-2 Therapy." Journal of Immunotoxicology, vol. 21, 2024, p. S48, https://doi.org/10.1080/1547691X.2024.2343359.